An experimental gene-editing therapy has produced substantial and lasting reductions in dangerous blood fats after only a single treatment, offering early evidence that CRISPR technology could eventually transform how some severe cholesterol disorders are treated. Researchers from the Cleveland Clinic reported that a one-time infusion of the experimental therapy CTX310...
Menu